Scott Dreyer, EVP & Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 99,952 shares at $40.36 ($4.0M) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $4.0M COLL by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.36 | 46,417 | $1.9M | 46.4% |
| 2 | $40.36 | 46,417 | $1.9M | 46.4% |
| 3 | $40.99 | 3,559 | $146K | 3.6% |
| 4 | $40.99 | 3,559 | $146K | 3.6% |
| Total | $40.41 avg | 99,952 | $4.0M | 100% |
| Filing → |
| COLL | SELL | 2025-08-15 | $370K | — | Filing → |
| COLL | SELL | 2025-03-24 | $1.2M | — | Filing → |
| COLL | SELL | 2025-03-18 | $462K | — | Filing → |